期刊
EXPERT OPINION ON THERAPEUTIC TARGETS
卷 20, 期 8, 页码 935-945出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.2016.1151003
关键词
Cancer; copper amine oxidases; fibrosis; lysyl oxidase propeptide; lysyl oxidases; lysyl tyrosylquinone
资金
- National Institutes of Health from the National Institute of Dental and Craniofacial Research (NIDCR) [R21DE023973]
Introduction: The lysyl oxidase family of enzymes is classically known as being required for connective tissue maturation by oxidizing lysine residues in elastin and lysine and hydroxylysine residues in collagen precursors. The resulting aldehydes then participate in cross-link formation, which is required for normal connective tissue integrity. These enzymes have biological functions that extend beyond this fundamental biosynthetic role, with contributions to angiogenesis, cell proliferation, and cell differentiation. Dysregulation of lysyl oxidases occurs in multiple pathologies including fibrosis, primary and metastatic cancers, and complications of diabetes in a variety of tissues.Areas covered: This review summarizes the major findings of novel roles for lysyl oxidases in pathologies, and highlights some of the potential therapeutic approaches that are in development and which stem from these new findings.Expert opinion: Fundamental questions remain regarding the mechanisms of novel biological functions of this family of proteins, and regarding functions that are independent of their catalytic enzyme activity. However, progress is underway in the development of isoform-specific pharmacologic inhibitors, potential therapeutic antibodies and gaining an increased understanding of both tumor suppressor and metastasis promotion activities. Ultimately, this is likely to lead to novel therapeutic agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据